Drug
Idp 123 Lotion
Idp 123 Lotion: highest development phase Phase 2, developed by Bausch Health. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bausch Health
Trials
| Drug | Phase | Indication |
|---|---|---|
| IDP-123 Lotion NCT02938494 | Phase 2 | Acne Vulgaris |
Latest
No recent events.
Follow Idp 123 Lotion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.